A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol

Vascular dementia is the second most common cause of dementia affecting over seven million people worldwide, yet there are no licensed treatments. There is an urgent need for a clinical trial in this patient group. Subcortical ischaemic vascular dementia is the most common variant of vascular dement...

Full description

Bibliographic Details
Main Authors:	Greenan, C, Murphy, L, Yu, L, Kehoe, P, Coulthard, E, Bath, P, Stewart, R, Jones, R, Corbett, A, Thomas, A, Connelly, P, Arrojo, F, Canning, R, Wallach, S, Henderson, C, McGuinness, B, O'Sullivan, M, Holmes, C, Knapp, M, Ballard, C, Passmore, P, AFFECT Investigators
Format:	Journal article
Language:	English
Published:	Biomed Central 2016

A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol

Similar Items